Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Colgate-Palmolive: A Dividend Stock With Sparkle to Spare


The stock of this global toothpaste giant is pricey, but it has raised its payout in each of the past 50 years and has a strong presence in emerging markets.

Looking for a dividend stock that will make you smile? Toothpaste giant Colgate-Palmolive (NYSE:CL) has been whitening and brightening portfolios for decades.

Over the past 20 years, the maker of oral care products, dish soap, deodorant, and pet food has posted a total return, including reinvested dividends, of 12.8% annually. That handily beats the 8.2% annual total return for the S&P 500 over the same period.

Past performance is no guarantee of future results, of course. And Colgate's stock isn't cheap: It trades at a multiple of 22.6 times 2012 earnings (excluding one-time items). But for long-term dividend investors, the global consumer products maker still has a lot going for it.
Here are five reasons to like Colgate's stock.

1. It's a Dividend Machine.

The New York-based company has been paying dividends uninterrupted since 1895, and it has raised its dividend in each of the past 50 years.

That includes a 10% hike in March, when the company also announced a two-for-one stock split, effective May 15. Stock splits by themselves don't add any value, but they often signal that a company is performing well. Likewise, dividend increases are a sign of confidence.

Colgate's dividend payout ratio is a comfortable 47% of earnings, and the company spins out ample cash to reinvest in its operations and pay dividends. The yield of 2.2% isn't huge, but "given Colgate's stable cash flow, we expect the dividend to continually increase over time," said Jack Russo, an analyst with Edward Jones. He expects the dividend to grow at about 7% annually over the next five years.

2. It's a Play on Emerging Markets.

Colgate generates nearly 80% of its revenue outside the United States, and about 50% from emerging markets. That's a good thing, because penetration of oral care products is much lower in developing countries, which means the long-term growth opportunities there are higher.

"For example, per-capita consumption of toothpaste in the US is about 550 grams per year. In China, this figure is about 250 grams, and in India it is about 125 grams," Stephen Boland, an analyst with Odlum Brown, said in a report. "Colgate is very deeply entrenched in many of the key emerging markets thanks to its early global expansion and its strong market share position."

3. Its Balance Sheet Is Solid.

Standard & Poor's rates Colgate's debt at AA-minus, or "very strong," and the company can easily cover its interest obligations, Russo said.

What's more, profit margins have grown over the past 20 years as Colgate cut costs and reinvested the savings to increase sales and market share. Russo expects sales to increase by about 5% annually over the next five years, with earnings per share climbing by about 9%.

4. Its Brands Are Strong.

Colgate controls about 45% of the global toothpaste market, and sells about one out of every three manual toothbrushes, but there's more to the company than teeth. Its stable of well-known brands includes Speed Stick, Irish Spring, Palmolive, Softsoap, Fleecy, Ajax, and Science Diet.

Strong brands give the company pricing power, and the focus on consumer staples makes the stock a defensive holding during economic downturns. With annual sales of more than $17 billion and a presence in about 200 countries, it also provides excellent geographic diversification.

5. Earnings Usually Meet-or Beat-Estimates.

Colgate, which is scheduled to release first-quarter results on Thursday, has matched analyst estimates in six of the past eight quarters, and exceeded estimates twice.

For the first quarter, analysts expect earnings of $1.32 per share, up from $1.24 a year earlier. The predictability of quarterly earnings provides some comfort to investors.

That said, Colgate isn't a slam dunk. It faces risks including currency fluctuations, rising input costs, and competition from Procter & Gamble (NYSE:PG), Unilever (NYSE:UL), and others.

Perhaps the biggest concern is the stock's valuation. Colgate's P/E multiple has been climbing steadily over the past few years, and at 22.6 is higher than its ten-year average of 20.2. The rich valuation explains why most analysts rate the stock a "hold." The danger with high P/E stocks is that, if growth slows or results disappoint, the shares could get hammered.

Patient investors could wait for such an opportunity before jumping in. Then again, given Colgate's track record, the stock could continue rising from current levels. That would certainly make shareholders smile.

Editor's Note: This article was written by John Heinzl of the Globe Investor.

Below, find some more great investing and trading content from MoneyShow:

An Easy Way to Scan for Opportunities

Are Defensive Stocks the Answer?

A Commodity ETF Growing Like a Weed

Twitter: @TopProsTopPicks
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos